Article Text

Download PDFPDF
Quetiapine more effective than placebo for depression in bipolar I and II disorder

Statistics from Altmetric.com

Footnotes

  • For correspondence: Michael H Thase, MD, Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center, 3811 O’Hara Street, Pittsburgh, USA; thaseme{at}upmc.edu

  • Source of funding: AstraZeneca Pharmaceuticals LP.

Footnotes

  • Competing interests: Dr Goodwin has been reimbursed by AstraZeneca for advice about the investigation of quetiapine for the presentation of the data presented in this paper at international meetings and CME activity on other topics. He has also advised the other companies with an interest in this field and presented at their educational meetings.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.